Nor-ursodeoxycholic acid in hepatobiliary diseases: A narrative review
Sayan Malakar, Neha Sood, Suprabhat Giri, Arghya Samanta · 2026
Read Nor-ursodeoxycholic acid in hepatobiliary diseases: A narrative review by Sayan Malakar, Neha Sood, Suprabhat Giri, Arghya Samanta (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13548203.txt.
Description
Sayan Malakar, Neha Sood, Suprabhat Giri, and Arghya Samanta review in 2026 a bile acid drug for liver and bile diseases. The drug is a shortened cousin of a drug already in use for such illness.
Because of its changed shape, the body does not tag it the usual way, and it loops between liver and bile in a way that raises output of a protective fluid. Animal work hints it may also slow scarring. Yet proof of safety and benefit in people is thin and mostly borrowed from animal studies. Trials in fatty liver disease gave mixed results. The review maps what is known and what still needs testing.
Catalog record
| CREATOR | Sayan Malakar, Neha Sood, Suprabhat Giri, Arghya Samanta |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |